НовостиBenzingaHC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $2 HC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $2 Benzinga 2026.10.26 10:31 (GMT+0) Открыть на Benzinga Другие новости